Annual EBIT
-$173.10 M
-$94.15 M-119.25%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual earnings before interest & taxes is -$173.10 million, with the most recent change of -$94.15 million (-119.25%) on December 31, 2022.
- During the last 3 years, KDNY annual EBIT has fallen by -$126.61 million (-272.36%).
Performance
KDNY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$70.38 M
-$9.49 M-15.59%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly earnings before interest & taxes is -$70.38 million, with the most recent change of -$9.49 million (-15.59%) on June 30, 2023.
- Over the past year, KDNY quarterly EBIT has dropped by -$31.71 million (-82.01%).
Performance
KDNY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$233.85 M
-$31.71 M-15.69%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM earnings before interest & taxes is -$233.85 million, with the most recent change of -$31.71 million (-15.69%) on June 30, 2023.
- Over the past year, KDNY TTM EBIT has dropped by -$150.63 million (-181.01%).
Performance
KDNY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KDNY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -119.3% | -82.0% | -181.0% |
| 3 y3 years | -272.4% | -808.3% | -1303.3% |
| 5 y5 years | -272.4% | -266.8% | -4745.6% |
KDNY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +119.3% | at low | -487.9% | at low | +209.8% | at low |
| 5 y | 5-year | +272.4% | at low | -487.9% | at low | +4745.6% | at low |
| alltime | all time | +272.4% | at low | -487.9% | at low | +4745.6% | at low |
Chinook Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$70.38 M(+15.6%) | -$233.85 M(+15.7%) |
| Mar 2023 | - | -$60.89 M(+15.7%) | -$202.14 M(+16.8%) |
| Dec 2022 | -$173.10 M(+119.3%) | -$52.64 M(+5.4%) | -$173.10 M(+69.2%) |
| Sep 2022 | - | -$49.94 M(+29.1%) | -$102.31 M(+22.9%) |
| Jun 2022 | - | -$38.67 M(+21.4%) | -$83.22 M(+10.2%) |
| Mar 2022 | - | -$31.85 M(-275.6%) | -$75.49 M(-4.4%) |
| Dec 2021 | -$78.95 M | $18.14 M(-158.8%) | -$78.95 M(-39.0%) |
| Sep 2021 | - | -$30.84 M(-0.3%) | -$129.50 M(+18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$30.94 M(-12.4%) | -$109.13 M(+27.0%) |
| Mar 2021 | - | -$35.31 M(+9.0%) | -$85.94 M(+57.1%) |
| Dec 2020 | -$54.72 M(+17.7%) | -$32.41 M(+209.4%) | -$54.72 M(+588.6%) |
| Sep 2020 | - | -$10.47 M(+35.2%) | -$7.95 M(-52.3%) |
| Jun 2020 | - | -$7.75 M(+89.5%) | -$16.66 M(+86.9%) |
| Mar 2020 | - | -$4.09 M(-128.5%) | -$8.91 M(+84.7%) |
| Dec 2019 | -$46.49 M | $14.37 M(-174.9%) | -$4.83 M(-74.9%) |
| Sep 2019 | - | -$19.19 M | -$19.19 M |
FAQ
- What is Chinook Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Chinook Therapeutics?
- What is Chinook Therapeutics annual EBIT year-on-year change?
- What is Chinook Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly EBIT year-on-year change?
- What is Chinook Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Chinook Therapeutics?
- What is Chinook Therapeutics TTM EBIT year-on-year change?
What is Chinook Therapeutics annual earnings before interest & taxes?
The current annual EBIT of KDNY is -$173.10 M
What is the all time high annual EBIT for Chinook Therapeutics?
Chinook Therapeutics all-time high annual earnings before interest & taxes is -$46.49 M
What is Chinook Therapeutics annual EBIT year-on-year change?
Over the past year, KDNY annual earnings before interest & taxes has changed by -$94.15 M (-119.25%)
What is Chinook Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of KDNY is -$70.38 M
What is the all time high quarterly EBIT for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly earnings before interest & taxes is $18.14 M
What is Chinook Therapeutics quarterly EBIT year-on-year change?
Over the past year, KDNY quarterly earnings before interest & taxes has changed by -$31.71 M (-82.01%)
What is Chinook Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of KDNY is -$233.85 M
What is the all time high TTM EBIT for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM earnings before interest & taxes is -$4.83 M
What is Chinook Therapeutics TTM EBIT year-on-year change?
Over the past year, KDNY TTM earnings before interest & taxes has changed by -$150.63 M (-181.01%)